ReviewFrontiers in pharmacology2022

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential.

Hang Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.